Search Results

Search results for "PTAB 101", has returned "10" results.

PTAB Reverses §101 and §103 Rejections for Plant Extract

PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal Board (PTAB) overturned ...

Search Results

Search Results Search results for "PTAB 101", has returned "10" results. PTAB Reverses §101 and §103 Rejections for Plant Extract PTAB Reverses §101 and §103 Rejections for Plant Extract December ...

Four Decisions Designated Informative on 101: Positive Trend for Life Sciences?

Category: PTAB 101 ACCOLADES View Accolades CATEGORIES Pharma Alice Standard Federal Circuit USPTO PTAB Rules Cannabis Supreme Court Patent Eligibility 101 Mayo Myriad Gene Segments IPR Antibodies ...

Xiaohua (Joyce) Guo, Ph.D. - Blogs

PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...

Xiaohua (Joyce) Guo, Ph.D. - Blogs

PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...

Homepage

Category: PTAB 101 Statutory" Obviousness-Type Double Patenting for Pharma Patents? June 20, 2019 As all patent practitioners know, obviousness-type double patenting is a judicially created doctrine ...

Xiaohua (Joyce) Guo, Ph.D. - Blogs

PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...

Grace Kim - Blogs

PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...

Homepage

Two-Step Eligibility for Genomic Analysis Systems

In other words, the PTAB reversed the 101 rejection because the Examiner did not follow the USPTO’s guidance. In addition, this case should be a reminder that when the law (or guidance changes), it ...